Trial summary: This study will evaluate whether nutrition intervention can improve health-related quality of life following diagnosis of unresectable or borderline resectable pancreatic cancer.
Status: CLOSED
Trial identifier: ACTRN12624000084583
Sponsor: Monash University
Phase: N/A
Diagnosis: Locally advanced (Stage III) unresectable or metastatic (Stage IV) pancreatic ductal adenocarcinoma.
Line of therapy: N/A
Treatment: Dietetics counselling
  • Key inclusion criteria
    1. At least 18 years of age at time of screening
    2. Ability to provide informed consent and willing to comply with study procedures (i.e., completion of study outcome questionnaires, participation in intervention if randomised to intervention group)
    3. New diagnosis of borderline resectable, locally advanced, or metastatic pancreatic cancer commencing chemotherapy
    4. Life expectancy of at least 6 months from the time of screening as judged by the patient's health care team
    5. ECOG performance status score of less than or equal to 2
  • Key exclusion criteria
    1. Patients with neuroendocrine pancreatic cancers
    2. Patients who have previously had a pancreatic cancer surgical resection
    3. Patients who have received 2 or more cycles of chemotherapy for pancreatic cancer
    4. Patients with serious medical or psychiatric conditions that might compromise protocol-based management as judged by the patient's treating healthcare team
    5. Patients receiving ‘end of life’ care
    6. Patients who declined or are deemed unsuitable for systemic chemotherapy
    7. Patients with insufficient cognition to provide consent as judged by the patient's treating healthcare team
    8. Patients with insufficient knowledge of the English language who do not have a family member that can assist with English translation to facilitate completion of outcome data collection or interviews with the study dietitian

SuperQoL

Locations: Epworth Richmond.

Epworth PI: Mr Daniel Croagh

Jreissati Pancreatic Centre at Epworth 

Access this Clinical Trial

Healthcare professionals


Refer your patient

General enquiries

Please contact us for more information on 03 9426 8880 or email [email protected]


Back to all Clinical Trials and Research Studies